Insights into the T-cell response to SARS-CoV-2 Article Swipe
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1177/1721727x231211458
Following infection with SARS-CoV-2, cellular components of the adaptive immune system play a crucial role in eliminating the virus. Specifically, virus-specific CD4+ and CD8+ T cells generate effector cytokines and display cytotoxic activity. A number of studies carried out during the COVID-19 pandemic highlighted the importance of CD4+ T cells, CD8+ T cells, and memory cells in this process. T-cell responses emerge early and contribute to protection, but are comparatively impaired in severe cases, often accompanied by intense activation or lymphopenia. Since December 2020, SARS-CoV-2 vaccines have been licensed and administered worldwide. These vaccines induce a targeted T-cell response against SARS-CoV-2. The cellular response after the third dose was strong and superior to that obtained with the second dose. COVID-19 multiple vaccines elicit a robust CD4+ and CD8+ T cell response after the short-term booster. While, the T-cell response induced by COVID-19 vaccines has been shown to decline within 6-12 months of vaccination. In addition, the long-term persistence of cellular immunity may protect against the development of severe disease. In addition, adoptive T-cell therapies have shown considerable potential in the development of COVID-19 traitement. These therapies involve the transfer of T cells with specific antiviral properties into patients to boost their immune response against SARS-CoV-2.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1177/1721727x231211458
- OA Status
- gold
- References
- 62
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4388312198
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4388312198Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1177/1721727x231211458Digital Object Identifier
- Title
-
Insights into the T-cell response to SARS-CoV-2Work title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-06-01Full publication date if available
- Authors
-
Chaimae Kadi, Nouhaila Najimi, M. Zakaria, Youssef Bakri, Elmtili Noureddine, Seghrouchni FouadList of authors in order
- Landing page
-
https://doi.org/10.1177/1721727x231211458Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1177/1721727x231211458Direct OA link when available
- Concepts
-
Cytotoxic T cell, Immunology, Immune system, CD8, Adoptive cell transfer, T cell, Acquired immune system, Immunity, Cellular immunity, Medicine, Biology, Virology, In vitro, BiochemistryTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
62Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4388312198 |
|---|---|
| doi | https://doi.org/10.1177/1721727x231211458 |
| ids.doi | https://doi.org/10.1177/1721727x231211458 |
| ids.openalex | https://openalex.org/W4388312198 |
| fwci | 0.0 |
| type | article |
| title | Insights into the T-cell response to SARS-CoV-2 |
| biblio.issue | |
| biblio.volume | 21 |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10118 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | SARS-CoV-2 and COVID-19 Research |
| topics[1].id | https://openalex.org/T10041 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9991000294685364 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2725 |
| topics[1].subfield.display_name | Infectious Diseases |
| topics[1].display_name | COVID-19 Clinical Research Studies |
| topics[2].id | https://openalex.org/T11368 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9970999956130981 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2728 |
| topics[2].subfield.display_name | Neurology |
| topics[2].display_name | Long-Term Effects of COVID-19 |
| is_xpac | False |
| apc_list.value | 2000 |
| apc_list.currency | USD |
| apc_list.value_usd | 2000 |
| apc_paid.value | 2000 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 2000 |
| concepts[0].id | https://openalex.org/C154317977 |
| concepts[0].level | 3 |
| concepts[0].score | 0.7166399955749512 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q376266 |
| concepts[0].display_name | Cytotoxic T cell |
| concepts[1].id | https://openalex.org/C203014093 |
| concepts[1].level | 1 |
| concepts[1].score | 0.6861492991447449 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[1].display_name | Immunology |
| concepts[2].id | https://openalex.org/C8891405 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6726545095443726 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[2].display_name | Immune system |
| concepts[3].id | https://openalex.org/C167672396 |
| concepts[3].level | 3 |
| concepts[3].score | 0.6110336780548096 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q417800 |
| concepts[3].display_name | CD8 |
| concepts[4].id | https://openalex.org/C90375314 |
| concepts[4].level | 4 |
| concepts[4].score | 0.5814868807792664 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q3537484 |
| concepts[4].display_name | Adoptive cell transfer |
| concepts[5].id | https://openalex.org/C2776090121 |
| concepts[5].level | 3 |
| concepts[5].score | 0.5609740614891052 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q193529 |
| concepts[5].display_name | T cell |
| concepts[6].id | https://openalex.org/C193419808 |
| concepts[6].level | 3 |
| concepts[6].score | 0.49650198221206665 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q1645075 |
| concepts[6].display_name | Acquired immune system |
| concepts[7].id | https://openalex.org/C2779341262 |
| concepts[7].level | 3 |
| concepts[7].score | 0.44743719696998596 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q182581 |
| concepts[7].display_name | Immunity |
| concepts[8].id | https://openalex.org/C3017875465 |
| concepts[8].level | 3 |
| concepts[8].score | 0.42874860763549805 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q189146 |
| concepts[8].display_name | Cellular immunity |
| concepts[9].id | https://openalex.org/C71924100 |
| concepts[9].level | 0 |
| concepts[9].score | 0.4183724522590637 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[9].display_name | Medicine |
| concepts[10].id | https://openalex.org/C86803240 |
| concepts[10].level | 0 |
| concepts[10].score | 0.416596382856369 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[10].display_name | Biology |
| concepts[11].id | https://openalex.org/C159047783 |
| concepts[11].level | 1 |
| concepts[11].score | 0.39026159048080444 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q7215 |
| concepts[11].display_name | Virology |
| concepts[12].id | https://openalex.org/C202751555 |
| concepts[12].level | 2 |
| concepts[12].score | 0.13075459003448486 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q221681 |
| concepts[12].display_name | In vitro |
| concepts[13].id | https://openalex.org/C55493867 |
| concepts[13].level | 1 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[13].display_name | Biochemistry |
| keywords[0].id | https://openalex.org/keywords/cytotoxic-t-cell |
| keywords[0].score | 0.7166399955749512 |
| keywords[0].display_name | Cytotoxic T cell |
| keywords[1].id | https://openalex.org/keywords/immunology |
| keywords[1].score | 0.6861492991447449 |
| keywords[1].display_name | Immunology |
| keywords[2].id | https://openalex.org/keywords/immune-system |
| keywords[2].score | 0.6726545095443726 |
| keywords[2].display_name | Immune system |
| keywords[3].id | https://openalex.org/keywords/cd8 |
| keywords[3].score | 0.6110336780548096 |
| keywords[3].display_name | CD8 |
| keywords[4].id | https://openalex.org/keywords/adoptive-cell-transfer |
| keywords[4].score | 0.5814868807792664 |
| keywords[4].display_name | Adoptive cell transfer |
| keywords[5].id | https://openalex.org/keywords/t-cell |
| keywords[5].score | 0.5609740614891052 |
| keywords[5].display_name | T cell |
| keywords[6].id | https://openalex.org/keywords/acquired-immune-system |
| keywords[6].score | 0.49650198221206665 |
| keywords[6].display_name | Acquired immune system |
| keywords[7].id | https://openalex.org/keywords/immunity |
| keywords[7].score | 0.44743719696998596 |
| keywords[7].display_name | Immunity |
| keywords[8].id | https://openalex.org/keywords/cellular-immunity |
| keywords[8].score | 0.42874860763549805 |
| keywords[8].display_name | Cellular immunity |
| keywords[9].id | https://openalex.org/keywords/medicine |
| keywords[9].score | 0.4183724522590637 |
| keywords[9].display_name | Medicine |
| keywords[10].id | https://openalex.org/keywords/biology |
| keywords[10].score | 0.416596382856369 |
| keywords[10].display_name | Biology |
| keywords[11].id | https://openalex.org/keywords/virology |
| keywords[11].score | 0.39026159048080444 |
| keywords[11].display_name | Virology |
| keywords[12].id | https://openalex.org/keywords/in-vitro |
| keywords[12].score | 0.13075459003448486 |
| keywords[12].display_name | In vitro |
| language | en |
| locations[0].id | doi:10.1177/1721727x231211458 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S177651330 |
| locations[0].source.issn | 1721-727X, 2058-7392 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1721-727X |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | European Journal of Inflammation |
| locations[0].source.host_organization | https://openalex.org/P4310320017 |
| locations[0].source.host_organization_name | SAGE Publishing |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320017 |
| locations[0].license | cc-by-nc |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | European Journal of Inflammation |
| locations[0].landing_page_url | https://doi.org/10.1177/1721727x231211458 |
| locations[1].id | pmh:oai:doaj.org/article:9179e9637794428f920407c0e152302e |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306401280 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[1].source.host_organization | |
| locations[1].source.host_organization_name | |
| locations[1].source.host_organization_lineage | |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | article |
| locations[1].license_id | |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | European Journal of Inflammation, Vol 21 (2023) |
| locations[1].landing_page_url | https://doaj.org/article/9179e9637794428f920407c0e152302e |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A5092634043 |
| authorships[0].author.orcid | https://orcid.org/0009-0005-7465-0510 |
| authorships[0].author.display_name | Chaimae Kadi |
| authorships[0].countries | MA |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210106432 |
| authorships[0].affiliations[0].raw_affiliation_string | Laboratory of Cell Immunology, Department of Immunology, National Institute of Hygiene, Rabat, Morocco |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I4210119819 |
| authorships[0].affiliations[1].raw_affiliation_string | Mohammed VI Center for Research & Innovation, Rabat, Morocco and Mohammed VI University of Sciences and Health, Casablanca, Morocco |
| authorships[0].institutions[0].id | https://openalex.org/I4210106432 |
| authorships[0].institutions[0].ror | https://ror.org/01ptsgx95 |
| authorships[0].institutions[0].type | facility |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210106432, https://openalex.org/I4210107929 |
| authorships[0].institutions[0].country_code | MA |
| authorships[0].institutions[0].display_name | Institut National d'Hygiène du Maroc |
| authorships[0].institutions[1].id | https://openalex.org/I4210119819 |
| authorships[0].institutions[1].ror | https://ror.org/01tezat55 |
| authorships[0].institutions[1].type | education |
| authorships[0].institutions[1].lineage | https://openalex.org/I4210119819 |
| authorships[0].institutions[1].country_code | MA |
| authorships[0].institutions[1].display_name | Université Mohammed VI des Sciences de la Santé |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Chaimae Kadi |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Laboratory of Cell Immunology, Department of Immunology, National Institute of Hygiene, Rabat, Morocco, Mohammed VI Center for Research & Innovation, Rabat, Morocco and Mohammed VI University of Sciences and Health, Casablanca, Morocco |
| authorships[1].author.id | https://openalex.org/A5040310281 |
| authorships[1].author.orcid | https://orcid.org/0009-0008-5536-0237 |
| authorships[1].author.display_name | Nouhaila Najimi |
| authorships[1].countries | MA |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210119819 |
| authorships[1].affiliations[0].raw_affiliation_string | Mohammed VI Center for Research & Innovation, Rabat, Morocco and Mohammed VI University of Sciences and Health, Casablanca, Morocco |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I4210106432 |
| authorships[1].affiliations[1].raw_affiliation_string | Laboratory of Cell Immunology, Department of Immunology, National Institute of Hygiene, Rabat, Morocco |
| authorships[1].affiliations[2].institution_ids | https://openalex.org/I126477371 |
| authorships[1].affiliations[2].raw_affiliation_string | Laboratory of Human Pathologies Biology and Center of Genomic of Human Pathologies Biology Faculty of Sciences, Mohammed V University, Rabat, Morocco |
| authorships[1].institutions[0].id | https://openalex.org/I4210106432 |
| authorships[1].institutions[0].ror | https://ror.org/01ptsgx95 |
| authorships[1].institutions[0].type | facility |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210106432, https://openalex.org/I4210107929 |
| authorships[1].institutions[0].country_code | MA |
| authorships[1].institutions[0].display_name | Institut National d'Hygiène du Maroc |
| authorships[1].institutions[1].id | https://openalex.org/I126477371 |
| authorships[1].institutions[1].ror | https://ror.org/00r8w8f84 |
| authorships[1].institutions[1].type | education |
| authorships[1].institutions[1].lineage | https://openalex.org/I126477371 |
| authorships[1].institutions[1].country_code | MA |
| authorships[1].institutions[1].display_name | Mohammed V University |
| authorships[1].institutions[2].id | https://openalex.org/I4210119819 |
| authorships[1].institutions[2].ror | https://ror.org/01tezat55 |
| authorships[1].institutions[2].type | education |
| authorships[1].institutions[2].lineage | https://openalex.org/I4210119819 |
| authorships[1].institutions[2].country_code | MA |
| authorships[1].institutions[2].display_name | Université Mohammed VI des Sciences de la Santé |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Nouhaila Najimi |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Laboratory of Cell Immunology, Department of Immunology, National Institute of Hygiene, Rabat, Morocco, Laboratory of Human Pathologies Biology and Center of Genomic of Human Pathologies Biology Faculty of Sciences, Mohammed V University, Rabat, Morocco, Mohammed VI Center for Research & Innovation, Rabat, Morocco and Mohammed VI University of Sciences and Health, Casablanca, Morocco |
| authorships[2].author.id | https://openalex.org/A5112735229 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | M. Zakaria |
| authorships[2].countries | MA |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I240042149 |
| authorships[2].affiliations[0].raw_affiliation_string | Laboratory of Biology and Health, Faculty of Sciences of Tetouan, Abdelmalek Essaâdi University, Tetouan, Morocco |
| authorships[2].institutions[0].id | https://openalex.org/I240042149 |
| authorships[2].institutions[0].ror | https://ror.org/03c4shz64 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I240042149 |
| authorships[2].institutions[0].country_code | MA |
| authorships[2].institutions[0].display_name | Abdelmalek Essaâdi University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Menanne Zakaria |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Laboratory of Biology and Health, Faculty of Sciences of Tetouan, Abdelmalek Essaâdi University, Tetouan, Morocco |
| authorships[3].author.id | https://openalex.org/A5055539504 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-5972-2353 |
| authorships[3].author.display_name | Youssef Bakri |
| authorships[3].countries | MA |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I126477371 |
| authorships[3].affiliations[0].raw_affiliation_string | Laboratory of Human Pathologies Biology and Center of Genomic of Human Pathologies Biology Faculty of Sciences, Mohammed V University, Rabat, Morocco |
| authorships[3].institutions[0].id | https://openalex.org/I126477371 |
| authorships[3].institutions[0].ror | https://ror.org/00r8w8f84 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I126477371 |
| authorships[3].institutions[0].country_code | MA |
| authorships[3].institutions[0].display_name | Mohammed V University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Bakri Youssef |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Laboratory of Human Pathologies Biology and Center of Genomic of Human Pathologies Biology Faculty of Sciences, Mohammed V University, Rabat, Morocco |
| authorships[4].author.id | |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | |
| authorships[4].countries | MA |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I240042149 |
| authorships[4].affiliations[0].raw_affiliation_string | Laboratory of Biology and Health, Faculty of Sciences of Tetouan, Abdelmalek Essaâdi University, Tetouan, Morocco |
| authorships[4].institutions[0].id | https://openalex.org/I240042149 |
| authorships[4].institutions[0].ror | https://ror.org/03c4shz64 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I240042149 |
| authorships[4].institutions[0].country_code | MA |
| authorships[4].institutions[0].display_name | Abdelmalek Essaâdi University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Elmtili Noureddine |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Laboratory of Biology and Health, Faculty of Sciences of Tetouan, Abdelmalek Essaâdi University, Tetouan, Morocco |
| authorships[5].author.id | https://openalex.org/A5111068732 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Seghrouchni Fouad |
| authorships[5].countries | MA |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210119819 |
| authorships[5].affiliations[0].raw_affiliation_string | Mohammed VI Center for Research & Innovation, Rabat, Morocco and Mohammed VI University of Sciences and Health, Casablanca, Morocco |
| authorships[5].institutions[0].id | https://openalex.org/I4210119819 |
| authorships[5].institutions[0].ror | https://ror.org/01tezat55 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210119819 |
| authorships[5].institutions[0].country_code | MA |
| authorships[5].institutions[0].display_name | Université Mohammed VI des Sciences de la Santé |
| authorships[5].author_position | last |
| authorships[5].raw_author_name | Seghrouchni Fouad |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Mohammed VI Center for Research & Innovation, Rabat, Morocco and Mohammed VI University of Sciences and Health, Casablanca, Morocco |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1177/1721727x231211458 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Insights into the T-cell response to SARS-CoV-2 |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10118 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | SARS-CoV-2 and COVID-19 Research |
| related_works | https://openalex.org/W570146172, https://openalex.org/W2986423947, https://openalex.org/W2422241218, https://openalex.org/W3132807398, https://openalex.org/W1920651514, https://openalex.org/W1495969056, https://openalex.org/W2419578556, https://openalex.org/W1966113031, https://openalex.org/W2561535599, https://openalex.org/W2361550127 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1177/1721727x231211458 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S177651330 |
| best_oa_location.source.issn | 1721-727X, 2058-7392 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1721-727X |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | European Journal of Inflammation |
| best_oa_location.source.host_organization | https://openalex.org/P4310320017 |
| best_oa_location.source.host_organization_name | SAGE Publishing |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320017 |
| best_oa_location.license | cc-by-nc |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | European Journal of Inflammation |
| best_oa_location.landing_page_url | https://doi.org/10.1177/1721727x231211458 |
| primary_location.id | doi:10.1177/1721727x231211458 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S177651330 |
| primary_location.source.issn | 1721-727X, 2058-7392 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1721-727X |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | European Journal of Inflammation |
| primary_location.source.host_organization | https://openalex.org/P4310320017 |
| primary_location.source.host_organization_name | SAGE Publishing |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320017 |
| primary_location.license | cc-by-nc |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | European Journal of Inflammation |
| primary_location.landing_page_url | https://doi.org/10.1177/1721727x231211458 |
| publication_date | 2023-06-01 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W3172356334, https://openalex.org/W3176141337, https://openalex.org/W3089992403, https://openalex.org/W3138672464, https://openalex.org/W3046194290, https://openalex.org/W3025320502, https://openalex.org/W3082438395, https://openalex.org/W3041494167, https://openalex.org/W3194862570, https://openalex.org/W3042183476, https://openalex.org/W4210792795, https://openalex.org/W3141087105, https://openalex.org/W3211023780, https://openalex.org/W3160457193, https://openalex.org/W3038964751, https://openalex.org/W3160504045, https://openalex.org/W3119858919, https://openalex.org/W3086049345, https://openalex.org/W3087319520, https://openalex.org/W3024643080, https://openalex.org/W3007940623, https://openalex.org/W3155566633, https://openalex.org/W3106384901, https://openalex.org/W3094123349, https://openalex.org/W3141611421, https://openalex.org/W3120192666, https://openalex.org/W3041115282, https://openalex.org/W3090209951, https://openalex.org/W2796489672, https://openalex.org/W2978810851, https://openalex.org/W3042328892, https://openalex.org/W3178981008, https://openalex.org/W3145275749, https://openalex.org/W2061242425, https://openalex.org/W3208089728, https://openalex.org/W1981480494, https://openalex.org/W2088350724, https://openalex.org/W3121008609, https://openalex.org/W3137992437, https://openalex.org/W3048775784, https://openalex.org/W3152827077, https://openalex.org/W3125067742, https://openalex.org/W2075681678, https://openalex.org/W3110730557, https://openalex.org/W3012421327, https://openalex.org/W3047996214, https://openalex.org/W3123130740, https://openalex.org/W3011812996, https://openalex.org/W2039876970, https://openalex.org/W3023991776, https://openalex.org/W3033419598, https://openalex.org/W3036397333, https://openalex.org/W3014333693, https://openalex.org/W3113734454, https://openalex.org/W3127329393, https://openalex.org/W3119345685, https://openalex.org/W3042833857, https://openalex.org/W3153508314, https://openalex.org/W3111255098, https://openalex.org/W3169082905, https://openalex.org/W3111590711, https://openalex.org/W3022986726 |
| referenced_works_count | 62 |
| abstract_inverted_index.A | 33 |
| abstract_inverted_index.T | 24, 48, 51, 128, 190 |
| abstract_inverted_index.a | 12, 95, 123 |
| abstract_inverted_index.In | 153, 169 |
| abstract_inverted_index.by | 76, 140 |
| abstract_inverted_index.in | 15, 56, 71, 178 |
| abstract_inverted_index.of | 6, 35, 46, 151, 158, 166, 181, 189 |
| abstract_inverted_index.or | 79 |
| abstract_inverted_index.to | 65, 112, 146, 198 |
| abstract_inverted_index.The | 101 |
| abstract_inverted_index.and | 22, 29, 53, 63, 89, 110, 126 |
| abstract_inverted_index.are | 68 |
| abstract_inverted_index.but | 67 |
| abstract_inverted_index.has | 143 |
| abstract_inverted_index.may | 161 |
| abstract_inverted_index.out | 38 |
| abstract_inverted_index.the | 7, 17, 40, 44, 105, 116, 132, 136, 155, 164, 179, 187 |
| abstract_inverted_index.was | 108 |
| abstract_inverted_index.6-12 | 149 |
| abstract_inverted_index.CD4+ | 21, 47, 125 |
| abstract_inverted_index.CD8+ | 23, 50, 127 |
| abstract_inverted_index.been | 87, 144 |
| abstract_inverted_index.cell | 129 |
| abstract_inverted_index.dose | 107 |
| abstract_inverted_index.have | 86, 174 |
| abstract_inverted_index.into | 196 |
| abstract_inverted_index.play | 11 |
| abstract_inverted_index.role | 14 |
| abstract_inverted_index.that | 113 |
| abstract_inverted_index.this | 57 |
| abstract_inverted_index.with | 2, 115, 192 |
| abstract_inverted_index.2020, | 83 |
| abstract_inverted_index.Since | 81 |
| abstract_inverted_index.These | 92, 184 |
| abstract_inverted_index.after | 104, 131 |
| abstract_inverted_index.boost | 199 |
| abstract_inverted_index.cells | 25, 55, 191 |
| abstract_inverted_index.dose. | 118 |
| abstract_inverted_index.early | 62 |
| abstract_inverted_index.often | 74 |
| abstract_inverted_index.shown | 145, 175 |
| abstract_inverted_index.their | 200 |
| abstract_inverted_index.third | 106 |
| abstract_inverted_index.T-cell | 59, 97, 137, 172 |
| abstract_inverted_index.While, | 135 |
| abstract_inverted_index.cases, | 73 |
| abstract_inverted_index.cells, | 49, 52 |
| abstract_inverted_index.during | 39 |
| abstract_inverted_index.elicit | 122 |
| abstract_inverted_index.emerge | 61 |
| abstract_inverted_index.immune | 9, 201 |
| abstract_inverted_index.induce | 94 |
| abstract_inverted_index.memory | 54 |
| abstract_inverted_index.months | 150 |
| abstract_inverted_index.number | 34 |
| abstract_inverted_index.robust | 124 |
| abstract_inverted_index.second | 117 |
| abstract_inverted_index.severe | 72, 167 |
| abstract_inverted_index.strong | 109 |
| abstract_inverted_index.system | 10 |
| abstract_inverted_index.virus. | 18 |
| abstract_inverted_index.within | 148 |
| abstract_inverted_index.against | 99, 163, 203 |
| abstract_inverted_index.carried | 37 |
| abstract_inverted_index.crucial | 13 |
| abstract_inverted_index.decline | 147 |
| abstract_inverted_index.display | 30 |
| abstract_inverted_index.induced | 139 |
| abstract_inverted_index.intense | 77 |
| abstract_inverted_index.involve | 186 |
| abstract_inverted_index.protect | 162 |
| abstract_inverted_index.studies | 36 |
| abstract_inverted_index.COVID-19 | 41, 119, 141, 182 |
| abstract_inverted_index.December | 82 |
| abstract_inverted_index.adaptive | 8 |
| abstract_inverted_index.adoptive | 171 |
| abstract_inverted_index.booster. | 134 |
| abstract_inverted_index.cellular | 4, 102, 159 |
| abstract_inverted_index.disease. | 168 |
| abstract_inverted_index.effector | 27 |
| abstract_inverted_index.generate | 26 |
| abstract_inverted_index.immunity | 160 |
| abstract_inverted_index.impaired | 70 |
| abstract_inverted_index.licensed | 88 |
| abstract_inverted_index.multiple | 120 |
| abstract_inverted_index.obtained | 114 |
| abstract_inverted_index.pandemic | 42 |
| abstract_inverted_index.patients | 197 |
| abstract_inverted_index.process. | 58 |
| abstract_inverted_index.response | 98, 103, 130, 138, 202 |
| abstract_inverted_index.specific | 193 |
| abstract_inverted_index.superior | 111 |
| abstract_inverted_index.targeted | 96 |
| abstract_inverted_index.transfer | 188 |
| abstract_inverted_index.vaccines | 85, 93, 121, 142 |
| abstract_inverted_index.Following | 0 |
| abstract_inverted_index.activity. | 32 |
| abstract_inverted_index.addition, | 154, 170 |
| abstract_inverted_index.antiviral | 194 |
| abstract_inverted_index.cytokines | 28 |
| abstract_inverted_index.cytotoxic | 31 |
| abstract_inverted_index.infection | 1 |
| abstract_inverted_index.long-term | 156 |
| abstract_inverted_index.potential | 177 |
| abstract_inverted_index.responses | 60 |
| abstract_inverted_index.therapies | 173, 185 |
| abstract_inverted_index.SARS-CoV-2 | 84 |
| abstract_inverted_index.activation | 78 |
| abstract_inverted_index.components | 5 |
| abstract_inverted_index.contribute | 64 |
| abstract_inverted_index.importance | 45 |
| abstract_inverted_index.properties | 195 |
| abstract_inverted_index.short-term | 133 |
| abstract_inverted_index.worldwide. | 91 |
| abstract_inverted_index.SARS-CoV-2, | 3 |
| abstract_inverted_index.SARS-CoV-2. | 100, 204 |
| abstract_inverted_index.accompanied | 75 |
| abstract_inverted_index.development | 165, 180 |
| abstract_inverted_index.eliminating | 16 |
| abstract_inverted_index.highlighted | 43 |
| abstract_inverted_index.persistence | 157 |
| abstract_inverted_index.protection, | 66 |
| abstract_inverted_index.traitement. | 183 |
| abstract_inverted_index.administered | 90 |
| abstract_inverted_index.considerable | 176 |
| abstract_inverted_index.lymphopenia. | 80 |
| abstract_inverted_index.vaccination. | 152 |
| abstract_inverted_index.Specifically, | 19 |
| abstract_inverted_index.comparatively | 69 |
| abstract_inverted_index.virus-specific | 20 |
| cited_by_percentile_year | |
| corresponding_author_ids | https://openalex.org/A5092634043 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 6 |
| corresponding_institution_ids | https://openalex.org/I4210106432, https://openalex.org/I4210119819 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8399999737739563 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.22490826 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |